Assignee
NAUREX INC
US·5 granted patents·15 pending applications·27 citations·filing 2013–2024
Top patents by PatentIndex Score
20 records- 0193US9708335B2Spiro-lactam NMDA receptor modulators and uses thereofNAUREX INC·Filed 2014·Granted Jul 18, 2017·22 cites·62 claims
- 0280US9745342B2NMDA receptor modulators and prodrugs, salts, and uses thereofNAUREX INC·Filed 2014·Granted Aug 29, 2017·5 cites·13 claims
- 0369US2022112239A1Process and intermediates for synthesis of peptide compoundsNAUREX INC·Filed 2021·Application pending·0 cites
- 0464US2025243211A1Processes and intermediates for producing diazaspiro lactam compoundsNAUREX INC·Filed 2024·Application pending·0 cites
- 0560US2020197365A1Treatment with nmda receptor modulatorsNAUREX INC·Filed 2018·Application pending·0 cites
- 0659US2019031715A1Process and intermediates for synthesis of peptide compoundsNAUREX INC·Filed 2018·Application pending·0 cites
- 0759US2020199173A1Process and intermediates for synthesis of peptide compoundsNAUREX INC·Filed 2018·Application pending·0 cites
- 0852US12215114B2Processes and intermediates for producing diazaspiro lactam compoundsNAUREX INC·Filed 2020·Granted Feb 4, 2025·0 cites·20 claims
- 0950US2018258139A1N-methyl-d-aspartate receptor modulators and methods of making and using sameNAUREX INC·Filed 2018·Application pending·0 cites
- 1050US2020368310A1Treatment with nmda receptor modulatorsNAUREX INC·Filed 2018·Application pending·0 cites
- 1149US2022024976A1Salt and crystalline forms of rapastinelNAUREX INC·Filed 2020·Application pending·0 cites
- 1248US2020254050A1Stable compositions of neuroactive peptidesNAUREX INC·Filed 2020·Application pending·0 cites
- 1347US10590167B2NMDA receptor modulators and prodrugs, salts, and uses thereofNAUREX INC·Filed 2017·Granted Mar 17, 2020·0 cites·12 claims
- 1447US2019351006A1Methods of administration of nmda receptor agonistsNAUREX INC·Filed 2018·Application pending·0 cites
- 1547US2014045943A1Hydroxamic Acid Derivatives, Preparation and Therapeutic Uses ThereofNAUREX INC·Filed 2013·Application pending·0 cites
- 1644US2022267341A1Solid forms of tert-butyl (s)-2((2s,3r)-1-amino-3-hydroxy-1-oxobu tan-2-yl)-1-oxo-2, 5-diazaspiro [3.4] octan e-5-carboxylate and methods of preparing themNAUREX INC·Filed 2020·Application pending·0 cites
- 1743US9994614B2N-methyl-D-aspartate receptor modulators and methods of making and using sameNAUREX INC·Filed 2015·Granted Jun 12, 2018·0 cites·9 claims
- 1840US2017049844A1Stable compositions of neuroactive peptidesNAUREX INC·Filed 2015·Application pending·0 cites
- 1940US2021198315A1Process for synthesis of peptide compoundsNAUREX INC·Filed 2017·Application pending·0 cites
- 2032US2017296616A1Methods of treating depression using nmda modulatorsNAUREX INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NAUREX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →